Prefilled syringes with high molecular weight linear biotech hyaluronic acid sodium salt (1.6% or 2%). New patented formula available. Volume of syringe from 2ml to 4ml for joint adaptability.

The role of intra-articular hyaluronic acid in the management of osteoarthritis is increasingly being recognized. Visco-supplementation with intra-articular hyaluronic acid has now become established therapy in osteoarthritis, with beneficial effects on pain, function, and patient global assessment.

Hyaluronic acid is an important component of the synovial fluid in the joints, both as lubricant and as absorbent of the mechanical stresses.

Furthermore, besides benefits on symptoms, recent published evidence has shown that the use of intra-articular hyaluronic acid can postpone knee replacement of up to 2.2 years thus bringing additional potential advantages such as: 

• postpone surgery;
• free up hospital rooms and medical personnel time;
• reduce waiting list.

The product is a medical device class III in prefilled syringe which contains high molecular weight linear biotech hyaluronic acid sodium salt 1.6% or 2%.

Indicated in case of pain or reduced mobility due to osteoarthritis, mechanical or degenerative joint disease.

The product is 100% European from raw materials up to finished product.